Perioperative blood transfusion and risk factors in elderly patients with hip fracture

doi:10.3969/j.issn.1006-7795.2021.04.019

Abstract

Abstract: Objective To evaluate the needs for perioperative allogeneic red blood cell transfusions (ABT) in elderly patients with hip fracture and the influence of different factors on ABT. Methods We conducted a study on elderly patients (≥65 years old) who were admitted to the geriatric trauma orthopedics ward of Beijing Jishuitan Hospital from January 2019 to December 2019 due to hip fracture. The perioperative data of the patients were collected, and univariate and multivariate stepwise Logistic regression analysis were performed to determine the risk factors for perioperative ABT. Results A total of 1 112 patients were included in this study, 50.6% of whom had a perioperative ABT. Univariate analysis showed that elderly patients with hip fracture in the perioperative ABT group were older, had more intraoperative blood loss (IBL), lower body mass index (BMI), lower hemoglobin and serum albumin at admission, longer prothrombin time (PT) and activated partial thromboplastin time (APTT), and shorter operative time. Female, intertrochanteric fractures, American Society of Anesthesiologists (ASA) classification ≥ Grade Ⅲ, general anesthesia, and patients without diabetes were more common. Multivariate stepwise Logistic regression analysis indicated that low hemoglobin at admission, intertrochanteric fracture, high IBL, advanced age, low BMI, ASA classification ≥Grade Ⅲ and general anesthesia were independent risk factors for perioperative ABT in elderly patients with hip fracture. Conclusion Perioperative ABT is very common in elderly patients with hip fracture. It is associated with low Hb at admission, intertrochanteric fracture, high IBL, advanced age, low BMI, ASA classification≥Grade Ⅲ and general anesthesia. These aspects can be considered to reduce perioperative ABT. Early and adequate blood preparation is required for the patients with immutable risk factors.

Key words: hip fracture, elderly patients, allogeneic red blood cell transfusions

CLC Number:

R687.4

Yue Rui, Li Xiaoyu, Yang Minghui, Zhang Ping. Perioperative blood transfusion and risk factors in elderly patients with hip fracture[J]. Journal of Capital Medical University, 2021, 42(4): 629-634.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2021.04.019

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2021/V42/I4/629

References

[1] 中国疾病预防控制中心慢性非传染性疾病预防控制中心,国家卫生健康委员会统计信息中心. 2018中国死因监测数据集[M]. 北京:中国科学技术出版社, 2019.
[2] Sri-On J, Tirrell G P, Bean J F, et al. Revisit, Subsequent Hospitalization, Recurrent Fall, and Death Within 6 Months After a Fall Among Elderly Emergency Department Patients. Ann Emerg Med, 2017,70(4):516-521.e2.
[3] 张瑞鹏, 尹英超, 李石伦, 等.髋部骨折指南解读与诊疗现状分析[J].河北医科大学学报,2018,39(6):621-622,627.
[4] Arshi A, Lai W C, Iglesias B C, et al. Blood transfusion rates and predictors following geriatric hip fracture surgery[J]. Hip Int. 2020 Jan 8:1120700019897878.
[5] Viberg B, Gundtoft P H, Schønnemann J, et al. Introduction of national guidelines for restrictive blood transfusion threshold for hip fracture patients-a consecutive cohort study based on complete follow-up in national databases[J]. J Orthop Surg Res, 2018, 13(1):116.
[6] Smeets S J M, Verbruggen J P A M, Poeze M. Effect of blood transfusion on survival after hip fracture surgery[J]. Eur J Orthop Surg Traumatol, 2018, 28(7):1297-1303.
[7] 周宗科, 翁习生, 孙天胜, 等. 中国骨科手术加速康复——围术期血液管理专家共识[J].中华骨与关节外科杂志,2017,10(1):1-7.
[8] Yoon B H, Lee B S, Won H, et al. Preoperative iron supplementation and restrictive transfusion strategy in hip fracture surgery[J]. Clin Orthop Surg, 2019, 11(3):265-269.
[9] Althoff F C, Neb H, Herrmann E, et al. Multimodal patient blood management program based on a three-pillar strategy: a systematic review and Meta-analysis[J]. Ann Surg, 2019,269(5):794-804.
[10] Carson J L, Stanworth S J, Roubinian N, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion[J]. Cochrane Database Syst Rev, 2016,10(10):CD002042.
[11] 解绪红, 严志强, 张栋武, 等. 老年髋部骨折围手术期限制性输血与开放性输血疗效对比研究[J].中国输血杂志, 2019, 32(7): 654-657.
[12] Wang J Q, Chen L Y, Jiang B J, et al. Development of a nomogram for predicting blood transfusion risk after hemiarthroplasty for femoral neck fractures in elderly patients[J]. Med Sci Monit, 2020,26:e920255.
[13] Mattisson L, Lapidus L J, Enocson A. What is the influence of a delay to surgery >24 hours on the rate of red blood cell transfusion in elderly patients with intertrochanteric or subtrochanteric hip fractures treated with cephalomedullary nails?[J]. J Orthop Trauma, 2018, 32(8):403-407.
[14] Wang J, Zhao Y, Jiang B, et al. Development of a nomogram to predict postoperative transfusion in the elderly after intramedullary nail fixation of femoral intertrochanteric fractures[J]. Clin Interv Aging, 2021,16:1-7.
[15] Desai S J, Wood K S, Marsh J, et al. Factors affecting transfusion requirement after hip fracture: can we reduce the need for blood?[J]. Can J Surg, 2014, 57(5):342-348.
[16] Martinsen M I, Valland H, Solheim L F, et al. A restrictive policy for red blood cell transfusion in older hip fracture patients: experiences from a patient register[J]. BMC Res Notes, 2016,9:75.
[17] Harper K D, Navo P, Ramsey F, et al. “Hidden” preoperative blood loss with extracapsular versus intracapsular hip fractures: what is the difference?[J]. Geriatr Orthop Surg Rehabil, 2017,8(4):202-207.
[18] Fazal M A, Bagley C, Garg P. Predictors for perioperative blood transfusion in elderly patients with extra capsular hip fractures treated with cephalo-medullary nailing[J]. Chin J Traumatol, 2018, 21(1):16-19.
[19] Xie J, Hu Q, Huang Q, et al. Efficacy and safety of tranexamic acid in geriatric hip fracture with hemiarthroplasty: a retrospective cohort study[J]. BMC Musculoskelet Disord, 2019, 20(1):304.
[20] Qi Y M, Wang H P, Li Y J, et al. The efficacy and safety of intravenous tranexamic acid in hip fracture surgery: A systematic review and meta-analysis[J]. J Orthop Translat, 2019,19:1-11.
[21] Frisch N, Wessell N M, Charters M, et al. Effect of body mass index on blood transfusion in total hip and knee arthroplasty[J]. Orthopedics, 2016,39(5):e844-849.
[22] Akinleye S D, Garofolo G, Culbertson M D, et al. The Role of BMI in Hip Fracture Surgery[J]. Geriatr Orthop Surg Rehabil, 2018,9:2151458517747414.
[23] Sathiyakumar V, Estevez-Ordonez D, Thakore R V, et al. American Society of Anesthesiologists Score as a predictive tool to optimize blood ordering for intraoperative transfusion in orthopaedic trauma cases[J]. J Surg Orthop Adv, 2016,25(2):105-109.
[24] 何永军. 全身麻醉与椎管内麻醉用于全髋关节置换术比较[J]. 浙江创伤外科,2017,22(2):371-372.
[25] Abdulhamid A K. Evaluation of the use of anti-platelet therapy throughout the peri-operative period in patients with femoral neck fracture surgery[J]. A retrospective cohort study. Int Orthop, 2020,44(9):1805-1813.
[26] 张丹妹,赵艳丽,冯志军.预防人工关节置换术后下肢深静脉血栓形成研究进展[J].临床误诊误治,2019,32(2):111-116.
[27] 肖宇威,赵宇,肖保辉,等.利伐沙班与低分子肝素用于复杂骨盆髋臼骨折术后下肢深静脉血栓的预防效果比较[J].解放军医药杂志,2019,31(7):42-45.
[28] 岳睿,李晓玉,杨明辉,等.高龄老年髋部骨折患者术前下肢深静脉血栓形成的危险因素[J].首都医科大学学报,2020,41(3):458-463.